Want to join the conversation?
$A's 4Q15 revenue was up 6.2% on a core basis from a year ago. This growth was driven by strength in Pharma, Food, and Diagnostics & Clinical end-markets. Geographically, the company saw core growth across all regions with particular strength in its liquid chromatography offering, CrossLab services & consumables and Diagnostics & Genomics products.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?